New Enterprise Associates

The Weekly Notable Startup Funding Report: 11/4/19 | 11/3/2019

The notable startup fundings for the week ending 11/2/19 featuring funding details for Vacasa, Datameer, Faire, and much much more. Particle $40.0M - Series C San Francisco-based Particle provides hardware and software tools to help users prototype, scale, and manage IoT products. Founded by Zach Supalla and Zachary Crockett in 2012, Particle has now raised a total of $74.6M in total equity funding and is backed by investors that include …

New Aetion Tool Brings Real-World Evidence Research to Small and Mid-Sized Pharma Companies | PR Newswire | 11/1/2019

… critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era. Aetion is based in New York City , and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, Amgen Ventures, UCB, and Horizon Health Services, Inc. Learn more at aetion.com , and follow us at @aetioninc . SOURCE Aetion Related Links …

Follow New Enterprise Associates:    

Rock-Bottom Drug Prices For Older Generic Drugs Contribute To Worsening Shortages, FDA Says | Kaiser Health News | 10/30/2019

A weekly round-up of stories related to pharmaceutical development and pricing. The New York Times: U.S. Blames Drug Shortages On Low Prices And A ‘Broken Marketplace’ Chronic drug shortages that threaten patient care are caused by rock-bottom prices for older generic medicines and a health care marketplace that doesn’t run on the rules of supply and demand, among other factors, according to a federal report published on Tuesday …

First Edition: October 30, 2019 | Kaiser Health News | 10/30/2019

Today’s early morning highlights from the major news organizations. California Healthline: California Nursing Home Residents Told To Find New Homes Some of California’s most vulnerable nursing home residents, many of whom have nowhere else to go, are receiving letters from their health care plans saying they are no longer eligible for long-term care. In one notable example, three dozen nursing home residents in San Luis Obispo County were informed …

IPO Update: Galera Therapeutics Proposes IPO Terms - Galera Therapeutics (Pending:GRTX) | Seeking Alpha | 10/29/2019

Quick Take Galera Therapeutics ( GRTX ) has filed to raise $75 million in an IPO, according to an amended S-1/A registration statement . The company is advancing a pipeline of treatment candidates for cancer-related conditions. GRTX has achieved very promising results in its Phase 2b trials. For life science investors with a very long hold time frame of at least 24 to 36 months, the IPO may be worth …

Ex-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics | 10/29/2019

Ex-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics Tuesday, October 29, 2019 4:29 p.m. CDT FILE PHOTO: FDA Commissioner Scott Gottlieb speaks during an interview with Reuters in New York City, U.S., November 26, 2018. REUTERS/Brend By Rebecca Spalding NEW YORK (Reuters) - As a private investor, former U.S. Food and Drug Administration Commissioner Scott Gottlieb is focused on an area where few have found success in recent …

Ex-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics | News | WIN 98.5 | 10/29/2019

Ex-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics Tuesday, October 29, 2019 5:29 p.m. EDT FILE PHOTO: FDA Commissioner Scott Gottlieb speaks during an interview with Reuters in New York City, U.S., November 26, 2018. REUTERS/Brend By Rebecca Spalding NEW YORK (Reuters) - As a private investor, former U.S. Food and Drug Administration Commissioner Scott Gottlieb is focused on an area where few have found success in recent …

Ex-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics | News | MIX-FM | 10/29/2019

Ex-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics Tuesday, October 29, 2019 5:29 p.m. EDT FILE PHOTO: FDA Commissioner Scott Gottlieb speaks during an interview with Reuters in New York City, U.S., November 26, 2018. REUTERS/Brend By Rebecca Spalding NEW YORK (Reuters) - As a private investor, former U.S. Food and Drug Administration Commissioner Scott Gottlieb is focused on an area where few have found success in recent …

Ex-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics | News | WIBQ | 10/29/2019

Ex-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics Tuesday, October 29, 2019 5:29 p.m. EDT FILE PHOTO: FDA Commissioner Scott Gottlieb speaks during an interview with Reuters in New York City, U.S., November 26, 2018. REUTERS/Brend By Rebecca Spalding NEW YORK (Reuters) - As a private investor, former U.S. Food and Drug Administration Commissioner Scott Gottlieb is focused on an area where few have found success in recent …

New Enterprise Associates Promotes Two on Healthcare Investing Team | 10/29/2019

By FinSMEs Menlo Park, CA-based global venture capital firm New Enterprise Associates has promoted two professionals on its healthcare investing team. In details, Ed Mathers, a healthcare investor focused on biotechnology and specialty pharmaceuticals, was promoted to General Partner. He joined NEA in 2008. Blake Wu, who currently focuses on investments in the healthcare services, healthcare IT and biopharma sectors and also works closely with NEA’s healthcare growth and …

New Enterprise Associates names two new partners | 10/29/2019

Californian fund manager New Enterprise Associates has bolstered its healthcare investment team with the promotion of Ed Mathers to general partner and Blake Wu to partner. Buyout Mike Didymus - October 29, 2019 German mid-market investor Halder has sealed the third deal from its recently-raised Halder VI, its first fundraise since spinning out of Gimv in 2013. Funds in Market Mike Didymus - October 29, 2019 Venture Capital fund of …

NEA Promotes Ed Mathers to General Partner and Blake Wu to Partner | 10/28/2019

NEA Promotes Ed Mathers to General Partner and Blake Wu to Partner Global Venture Capital Firm Announces Key Promotions on Healthcare Investing Team MENLO PARK, Calif., October 28, 2019– New Enterprise Associates, Inc. (NEA) today announced the promotion of Ed Mathers, a healthcare investor focused on biotechnology and specialty pharmaceuticals, to General Partner. Since joining NEA in 2008, Mathers has been a tremendous contributor to successful outcomes within the firm’s …

Arch Venture Partners sails past $600m Fund X goal | 10/28/2019

Infrastructure Jordan Williams - October 29, 2019 The New Mexico State Investment Council has reportedly committed $355m of new capital for a number of funds managed by Carlyle, Ares Management and others. People News Jordan Williams - October 29, 2019 Californian fund manager New Enterprise Associates has bolstered its healthcare investment team with the promotion of Ed Mathers to general partner and Blake Wu to partner. Buyout Mike Didymus - October 29, 2019 …

NEA promotes two | PE Hub | 10/28/2019

New Enterprise Associates Inc has promoted Ed Mathers to general partner. Also, the firm has promoted Blake Wu to partner on the healthcare investing team. Mathers first joined NEA in 2008 while Wu came on board in 2014. PRESS RELEASE Menlo Park, CA — Oct. 28, 2019 — New Enterprise Associates, Inc. (NEA) today announced the promotion of Ed Mathers, a healthcare investor focused on biotechnology and specialty pharmaceuticals, to General Partner …

13D filings by Paulson & Co., New enterprise Associates and Others. - Barron’s | 10/26/2019

13Ds are filed with the Securities and Exchange Commission within 10 days of an entity’s attaining a greater than 5% position in any class of a company’s securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material has been extracted from filings released by the SEC from Oct. 17 through Oct. 23, 2019. Source: InsiderScore.com Activist Holdings Callon Petroleum ( CPE ) Paulson & Co. disclosed on Oct …

Databricks raises $ 400 million worth $ 6.2 billion | 10/23/2019

Home / SmartTech / Databricks raises $ 400 million worth $ 6.2 billion Databricks raises $ 400 million worth $ 6.2 billion Google + Foresighted are the entrepreneurs who predicted that data would become the new oil, such as Ali Ghodsi, Andy Konwinski, Ion Stoica, Matei Zaharia, Patrick Wendell, Reynold Xin and Scott Shenker. You are the co-founder of Databricks, a San Francisco-based company that provides a suite of enterprise-scale scalable data science and …

Databricks raises $400 million at a $6.2 billion valuation | VentureBeat | 10/22/2019

October 22, 2019 10:00 AM Image Credit: Databricks Prescient are the entrepreneurs who predicted data would become the new oil, like Ali Ghodsi, Andy Konwinski, Ion Stoica, Matei Zaharia, Patrick Wendell, Reynold Xin, and Scott Shenker. They’re the cofounders of Databricks, a San Francisco-based company that provides a suite of enterprise-focused scalable data science and data engineering tools. Since 2013, the year Databricks opened for business, it’s had …

OmniSci Debuts ‘OmniSci for Good,’ Making Accelerated Analytics Accessible for Social Benefit | PR Newswire | 10/22/2019

… hardware, the platform is available in the cloud and on-premise. OmniSci originated from research at Harvard and MIT Computer Science and Artificial Intelligence Laboratory (CSAIL). OmniSci is funded by GV, In-Q-Tel, New Enterprise Associates (NEA), NVIDIA, Tiger Global Management, Vanedge Capital and Verizon Ventures. The company is headquartered in San Francisco . Learn more about OmniSci at www.omnisci.com . MEDIA CONTACT: Amy Dardinger SSPR 802/762-3094 (office) [email protected] SOURCE …

Qpex Biopharma and Brii Biosciences Enter Into a Strategic Collaboration to Develop and Commercialize Antibiotics for Drug-Resistant Infections in China | PR Newswire | 10/22/2019

SAN DIEGO Qpex Biopharma, Inc., a biopharmaceutical company dedicated to the discovery and development of innovative anti-infective therapies, today announced that it has entered into a multi-product collaboration with Brii Biosciences to develop and commercialize Qpex’s portfolio in China of potentially best-in-class therapies to treat a range of multi-drug resistant gram-negative infections. “We are thrilled to be working together with a team that shares …

Instabase Raises $105M to Reimagine Business Applications From the Ground Up | Business Wire | 10/21/2019

SAN FRANCISCO- Instabase , the platform company for business applications, today announced that it has raised $105 million in Series B funding, led by Index Ventures with participation from existing investors Greylock Partners, New Enterprise Associates (NEA), and Andreessen Horowitz. Additional participating investors include Spark Capital, Tribe Capital, SC Ventures, and Glynn Capital. This latest round brings Instabase’s total funding to $132 million and values the company at over $1 billion …

Medicare

New Aetion Tool Brings Real-World Evidence Research to Small and Mid-Sized Pharma Companies | PR Newswire | 11/1/2019

… analysis needed to unlock answers about the safety, effectiveness, and value of medical treatments. The combined IBM MarketScan Commercial and Medicare Supplemental Databases comprise one of the largest proprietary claims data sets available, which includes … based in New York City , and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, Amgen Ventures, UCB, and Horizon Health Services, Inc. Learn more …

New Aetion Tool Brings Real-World Evidence Research to Small and Mid-Sized Pharma Companies | The Wapakoneta Daily News | 11/1/2019

… analysis needed to unlock answers about the safety, effectiveness, and value of medical treatments. The combined IBM MarketScan Commercial and Medicare Supplemental Databases comprise one of the largest proprietary claims data sets available, which includes … based in New York City , and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, Amgen Ventures, UCB, and Horizon Health Services, Inc. Learn more …

Biotech

Term Sheet: Oct. 31, 2019 | 10/31/2019

… 3.5 million in Series A funding. Investors include Cultivation Capital. HEALTH & LIFE SCIENCES DEALS - Arranta Bio , a Watertown, Mass.-based biotech firm, raised $82 million in funding. Investors include Ampersand Capital Partners and Thermo Fisher … million in 2018 and has yet to post a revenue. New Enterprise Associates (32% pre-offering), Versant Ventures (32%) and Invus Opportunities (11.8%). It plans to list on the Nasdaq as “OYST.” Read more . EXITS …

Coursera and MathWorks Announce New Data Science Course | 10/31/2019

… and citizens with in-demand skills to build a competitive workforce. Coursera is backed by investors that include Kleiner Perkins, New Enterprise Associates, GSV Capital, Learn Capital, and SEEK Group. About MathWorks MathWorks is the … discovery, innovation, and development in automotive, aerospace, electronics, financial services, biotech-pharmaceutical, and other industries. MATLAB and Simulink are also fundamental teaching and research tools in the world’s universities and learning institutions. Founded in 1984 …

Medical Imaging

Coursera and MathWorks Announce New Data Science Course | 10/31/2019

… to start applying MATLAB to common analysis tasks found in applications such as autonomous systems, voice recognition, predictive maintenance, and medical imaging. “The data science skills gap spans industries and countries. We’re excited to launch … workforce. Coursera is backed by investors that include Kleiner Perkins, New Enterprise Associates, GSV Capital, Learn Capital, and SEEK Group. About MathWorks MathWorks is the leading developer of mathematical computing software. MATLAB, the language of …

Food and Drug Administration

Rock-Bottom Drug Prices For Older Generic Drugs Contribute To Worsening Shortages, FDA Says | Kaiser Health News | 10/30/2019

… factors, according to a federal report published on Tuesday. The report, the work of a task force led by the Food and Drug Administration and comprising representatives from various federal agencies, recommended that buyers like … of investments he would make in his new role at New Enterprise Associates, one of the country’s largest venture capital firms where he worked prior to his time in government. (Spalding, 10/29) The Hill: House …

First Edition: October 30, 2019 | Kaiser Health News | 10/30/2019

… factors, according to a federal report published on Tuesday. The report, the work of a task force led by the Food and Drug Administration and comprising representatives from various federal agencies, recommended that buyers like … of investments he would make in his new role at New Enterprise Associates, one of the country’s largest venture capital firms where he worked prior to his time in government. (10/29) The Associated Press: White …

Digital Health

No. 450: Worlds war, bombs blast and Delta delivers – plus, an all-time LI great calls it a career (kinda) | 10/30/2019

… S2G, CPT Capital, PeakState, SGH Capital, Twenty Two VC, Aera VC, XFactor Ventures and Climate Capital. + Avia , an Illinois-based digital health consultant, raised $22 million in funding led by First Trust Capital Partners, with … Capital Partners, Correlation Ventures, A&E Investment, Osage University Partners, New Enterprise Associates, GV and Amazon. Fashion police: Good luck at your trial, Liz. BELOW THE FOLD (All Hallows Eve Edition) That’s some great pumpkin …

Term Sheet: Oct. 29, 2019 | 10/29/2019

… Investors include H.I.G. BioHealth Partners, 7wire Ventures, SV Health Investors, and Bluestem Capital. - Sensely , a London and San Francisco-based digital health and insuretech platform, raised $15 million in funding. Aflac Corporate Ventures led the … raised $200 million for a 5G ecosystem venture fund. PEOPLE - New Enterprise Associates promoted Ed Mathers to general partner. . IF YOU LIKE THIS EMAIL… Share today’s Term Sheet with a friend . Did someone share this …

Clinical Data

ESSA Pharma: Promising Novel Therapy For Treatment Of Prostate Cancer - ESSA Pharma Inc. (NASDAQ:EPIX) | Seeking Alpha | 10/11/2019

… as a Director of the company since June 2015. Prior to joining ESSA, he had been a Venture Partner at New Enterprise Associates, Inc. From 2007 until 2012, Dr. Parkinson served as President and CEO … ESSA’s slide 17 below. There were some very encouraging pre-clinical data when EPI-7386 was used in an even longer time frame of 52 days in dosing mice. At a point where ENZ was …

Ivantis Completes Enrollment of International SPECTRUM Registry for Hydrus Microstent | PR Newswire | 10/10/2019

… have been extremely pleased by the strong reception of our Hydrus Microstent by the clinical community, and our long-term clinical data has been an important driver for this adoption.” About the Hydrus® Microstent Roughly … and commercialize new technologies to treat eye disease. Investors include New Enterprise Associates, Delphi Ventures, Foresite Capital, RA Capital Management, Ascension Ventures, EDBI, GBS Ventures, MemorialCare Innovation Fund, Merieux Development and Vertex HealthCare. The company …

National Institutes of Health

Fifteen Neurotechnology Startups to Present at 2019 Neurotech Leaders Forum in San Francisco | PR Newswire | 10/8/2019

… also feature presentations and panel discussions on important issues confronting the neurotechnology industry. Josh Makower , general partner at VC firm New Enterprise Associates, will keynote on the first day of the conference. Makower is cofounder … recipient of the Jacob Javits Neuroscience Investigator Award from the National Institutes of Health for distinguished contributions to neurological research. He is also the chief science advisor of Neurofocus Inc., the consumer neurotech spinoff company …

Qpex Biopharma Licenses Polymyxin Antimicrobial Program from Monash University to Address Drug-Resistant Infections | PR Newswire | 4/30/2019

… Jian Li , Ph.D. of Monash University by the National Institutes of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH). Scientists from Qpex collaborated as the designated industrial partner with … settings. Qpex was launched in October 2018 with investment from New Enterprise Associates, Adams Street Partners, LYZZ Capital, Hatteras Venture Partners and Stanford University Draper Fund. The company’s scientists and clinicians have a record of …

Pain Management

Scott Gottlieb joins Ateon’s board, Jonathan Bush named executive chairman of Firefly, and more digital health hires and departures | MobiHealthNews | 9/19/2019

… and advisory positions following his FDA departure, some of which include roles with nonprofit drug development group FasterCures, Pfizer and New Enterprise Associates. Former general manager of Fitbit Health Solutions Adam Pellegrini has departed the … patient experience — it’s inspiring.” Alongside news of new funding, VR pain management startup Karuna Labs announced new additions of a chief medical officer and chief technical officer to its management. The former is Dr. James …

Scott Gottlieb joins Aetion’s board, Jonathan Bush named executive chairman of Firefly, and more digital health hires and departures | MobiHealthNews | 9/19/2019

… and advisory positions following his FDA departure, some of which include roles with nonprofit drug development group FasterCures, Pfizer and New Enterprise Associates. Former general manager of Fitbit Health Solutions Adam Pellegrini has departed the … patient experience — it’s inspiring.” Alongside news of new funding, VR pain management startup Karuna Labs announced new additions of a chief medical officer and chief technical officer to its management. The former is Dr. James …

ACA

Leading Gig Platforms put Stride’s New Benefits Platform to Work | PR Newswire | 8/21/2019

… less time looking for their rewards and more time using them.” “The Stride Benefits Platform is an important part of Instacart’s new, more holistic suite of offerings and resources designed to support our shoppers in … wealth benefits and perks. The company is backed by Venrock, New Enterprise Associates and F-Prime Capital Partners. About DoorDash: Doordash is a technology platform that connects customers with their favorite local and national businesses …

From Universal Pictures Home Entertainment: THE BEST OF ENEMIES | PR Newswire | 5/22/2019

… ray TM , DVD and On Demand on July 2, 2019 from STXfilms and Universal Pictures Home Entertainment. The film stars Academy Award® nominee Taraji P. Henson ( Hidden Figures, “Empire”) and Academy Award® winner Sam Rockwell … largest distribution platform; Dominic Ng , Chairman of East West Bank ; New Enterprise Associates (NEA); DNS Capital (representing the business interests of Gigi Pritzker and her immediate family); and Beau Wrigley , former Chairman and CEO of …

Diagnostic Imaging

Largest Physician-Led Radiology Practice Radiology Partners Lands $700M | HIT Consultant | 7/24/2019

… our practice,” said Dr. Rod Owen, President and Board Chair at Scottsdale Medical Imaging, Co-Executive Vice-President of Southwest Diagnostic Imaging and RP Director. “We are deeply focused on our mission to transform radiology … Clark of SIH will join Mohamad Makhzoumi of existing investor New Enterprise Associates (NEA) as the only two institutional investors on RP’s 11-member board. The board is led by RP Chairman and CEO Rich …

Radiology Partners Receives $700 Million Investment from Starr Investment Holdings | Business Wire | 7/19/2019

… healthcare services businesses, will join RP’s Board of Directors. Geoff Clark of SIH will join Mohamad Makhzoumi of existing investor New Enterprise Associates (NEA) as the only two institutional investors on RP’s 11-member board … at Scottsdale Medical Imaging, Co-Executive Vice-President of Southwest Diagnostic Imaging and RP Director. “We are deeply focused on our mission to transform radiology, and this new investment will support our programs to develop …

Aetion

New Aetion Tool Brings Real-World Evidence Research to Small and Mid-Sized Pharma Companies | PR Newswire | 11/1/2019

NEW YORK , Nov. 1, 2019 /PRNewswire/ – Today Aetion , the health care technology company that delivers real-world evidence for life sciences companies, payers, and regulatory agencies, announced a new integrated solution focused on advancing the … based in New York City , and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, Amgen Ventures, UCB, and Horizon Health Services, Inc. Learn more …

New Aetion Tool Brings Real-World Evidence Research to Small and Mid-Sized Pharma Companies | The Wapakoneta Daily News | 11/1/2019

NEW YORK , Nov. 1, 2019 /PRNewswire/ – Today Aetion , the health care technology company that delivers real-world evidence for life sciences companies, payers, and regulatory agencies, announced a new integrated solution focused on advancing the … based in New York City , and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, Amgen Ventures, UCB, and Horizon Health Services, Inc. Learn more …

Pfizer

Rock-Bottom Drug Prices For Older Generic Drugs Contribute To Worsening Shortages, FDA Says | Kaiser Health News | 10/30/2019

… FDA in April, Gottlieb has revealed little about what types of investments he would make in his new role at New Enterprise Associates, one of the country’s largest venture capital firms where he worked prior … to the left, sources say. (Sullivan, 10/30) The Associated Press: Pfizer Narrows Its Focus And Profit Soars In 3Q Pfizer’s third-quarter profit nearly doubled after it booked an $8.1 billion gain on paper by …

Ex-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics | 10/30/2019

… FDA in April, Gottlieb has revealed little about what types of investments he would make in his new role at New Enterprise Associates, one of the country’s largest venture capital firms where he worked prior … similar moves made by peers AstraZeneca Plc and Sanofi SA. Pfizer Inc, whose board Gottlieb joined in June after leaving government, is one of the few remaining large players still in the space along with …

Novartis

Ex-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics | 10/30/2019

… FDA in April, Gottlieb has revealed little about what types of investments he would make in his new role at New Enterprise Associates, one of the country’s largest venture capital firms where he worked prior … effective the less they are used. Last year, pharmaceutical giant Novartis AG said it would abandon its antibiotic research, following similar moves made by peers AstraZeneca Plc and Sanofi SA. Pfizer Inc, whose board Gottlieb …

IPO Update: Galera Therapeutics Proposes IPO Terms - Galera Therapeutics (Pending:GRTX) | Seeking Alpha | 10/29/2019

… New Enterprise Associates, Rock Springs Capital, Adage Capital Management, Tekla Capital Management, Correlation Ventures, Novartis Venture Fund ( NVS ), Novo Ventures, Clarus Ventures, and Sofinnova Investments among others. Source: Crunchbase Market According to a 2019 market research report by Meticulous Research, the global radiotherapy market is projected to reach $10.15 billion by 2025, growing at a CAGR of 5.6% between 2019 and 2025. According to data from GLOBOCAN, in 2012, about …

GlaxoSmithKline

Ex-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics | 10/30/2019

… FDA in April, Gottlieb has revealed little about what types of investments he would make in his new role at New Enterprise Associates, one of the country’s largest venture capital firms where he worked prior … few remaining large players still in the space along with GlaxoSmithKline Plc, which this week begun late-stage testing of an experimental antibiotic in patients with urinary tract infections and gonorrhea. Smaller players, meanwhile, have …

Ex-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics | 10/29/2019

… FDA in April, Gottlieb has revealed little about what types of investments he would make in his new role at New Enterprise Associates, one of the country’s largest venture capital firms where he worked prior … few remaining large players still in the space along with GlaxoSmithKline Plc GSK.L , which this week begun late-stage testing of an experimental antibiotic in patients with urinary tract infections and gonorrhea. Smaller players, meanwhile …

OrbiMed

Term Sheet: Oct. 29, 2019 | 10/29/2019

… shares priced between $14 to $16. The firm posted revenue of $8.3 million in 2018 and loss of $29.9 million. OrbiMed (34.6% pre-offering), Quaker BioVentures (21.2%), and Pacira Pharmaceuticals (13.6%) back the firm. It … raised $200 million for a 5G ecosystem venture fund. PEOPLE - New Enterprise Associates promoted Ed Mathers to general partner. . IF YOU LIKE THIS EMAIL… Share today’s Term Sheet with a friend . Did someone share this …

Term Sheet: Oct. 28, 2019 | 10/28/2019

… of between $14 to $16. It has yet to post a revenue and posted losses of $30 million in 2018. New Enterprise Associates (20.4% pre-offering), Novartis Bioventures (17%), and Novo Nordisk (15%) back the … a revenue and posted losses of $16.2 million in 2018. OrbiMed (41.2% pre-offering), Longitude Venture Partners (24.9%), and RA Capital (21.6%) back the firm. It plans to list on the Nasdaq as “ETNB.” Read …

Boston Scientific

SetPoint Medical Announces Oral Presentation of Results from U.S. Pilot Study in Rheumatoid Arthritis Patients at American College of Rheumatology (ACR) Annual Meeting 2019 | Globe Newswire | 10/29/2019

New Enterprise Associates (NEA), Morgenthaler Ventures, Topspin Partners, Sightline Partners, GlaxoSmithKline’s Action Potential Venture Capital and Boston Scientific as well as an additional undisclosed strategic investor (leading medical device company). For more information, visit www.setpointmedical.com . Contacts …

SetPoint Medical Announces Oral Presentation of Results from U.S. Pilot Study in Rheumatoid Arthritis Patients at American College of Rheumatology (ACR) Annual Meeting 2019 | BioSpace | 10/29/2019

New Enterprise Associates (NEA), Morgenthaler Ventures, Topspin Partners, Sightline Partners, GlaxoSmithKline’s Action Potential Venture Capital and Boston Scientific as well as an additional undisclosed strategic investor (leading medical device company). For more information, visit www.setpointmedical.com . Contacts Media Contact: Kirsten Thomas The Ruth Group 508-280-6592 [email protected] Investor Relation Contact: Emma Poalillo The Ruth Group 646-536-7000 [email protected]

Novo Nordisk

Term Sheet: Oct. 28, 2019 | 10/28/2019

New Enterprise Associates (20.4% pre-offering), Novartis Bioventures (17%), and Novo Nordisk (15%) back the firm. It plans to list on the Nasdaq as “GRTX.” Read more . - 89bio , a San Francisco-based biotech focused on metabolic diseases, plans to raise $70.4 million in an IPO of 4.4 million shares priced at a range of between $15 to $17. It has yet to post a revenue and posted losses of $16.2 …

Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development | PR Newswire | 12/7/2017

… biotechnology company focused on drug development, today announced it has closed a $22M Series B financing led by new investor New Enterprise Associates (NEA), along with participation from existing investors ARCH, Polaris, venBio, and Alexandria … program, a first-in-class insulin sensitizer, in collaboration with Novo Nordisk. “We are thrilled to have NEA as a new investor along with the addition of Dr. Gallagher to our board,” said Ken Song …

Fitbit

Scott Gottlieb joins Ateon’s board, Jonathan Bush named executive chairman of Firefly, and more digital health hires and departures | MobiHealthNews | 9/19/2019

Also: Amy McDonough steps up as GM and SVP of Fitbit Health; Cala Health appoints Renee Ryan as CEO; Craig Maloney joins Maestro Health. Scott Gottlieb joins Ateon’s board, Jonathan Bush named executive chairman of … include roles with nonprofit drug development group FasterCures, Pfizer and New Enterprise Associates. Former general manager of Fitbit Health Solutions Adam Pellegrini has departed the wearables maker in favor of a new role as SVP …

Scott Gottlieb joins Aetion’s board, Jonathan Bush named executive chairman of Firefly, and more digital health hires and departures | MobiHealthNews | 9/19/2019

Also: Amy McDonough steps up as GM and SVP of Fitbit Health; Cala Health appoints Renee Ryan as CEO; Craig Maloney joins Maestro Health. Scott Gottlieb joins Aetion’s board, Jonathan Bush named executive chairman of … include roles with nonprofit drug development group FasterCures, Pfizer and New Enterprise Associates. Former general manager of Fitbit Health Solutions Adam Pellegrini has departed the wearables maker in favor of a new role as SVP …

Genentech

VC-backed Pionyr names Levey as SVP and chief business officer | PE Hub | 8/27/2019

… officer. Previously, Levey worked at Tempest Therapeutics where she was vice president and chief business officer. Pionyr’s backers included OrbiMed, New Enterprise Associates, Sofinnova, SV Health Investors, Vida Ventures, Trinitas Capital, Mission Bay Capital and … player in early antibody phage-display technology platforms, formerly at Genentech, and is now head of protein engineering and antibody discovery at the University of Toronto. PIONYR is exploiting novel target discovery and antibody generation …

Live Long And Prosper: How Anne Wojcicki’s 23andMe Will Mine Its Giant DNA Database For Health And Wealth | Forbes | 6/6/2019

New Enterprise Associates and Genentech, 23andMe launched its first product in November 2007. The spit test cost $999 . Customers learned about their ancestry, their likelihood of going bald and their risk for some common health conditions like heart disease. The company skirted FDA regulations by advertising itself as a fun way for people to get insight into their DNA, rather than as a medical tool. At the time, it cost …

Apple Health

Eargo Continues Momentous Growth With New CFO, CMO, and VP of Software Engineering | PRWeb | 7/17/2019

… D round and its third product release, the award-winning health tech company brings on talent from Tesla, Visa, and Apple SAN JOSE, Calif. Eargo the direct-to-consumer health tech company destigmatizing hearing loss … round announced in March, which included participation from existing investors New Enterprise Associates (NEA), the Charles and Helen Schwab Foundation, Nan Fung Life Sciences, Maveron and new investor Future Fund, Australia’s sovereign wealth fund. Today’s …

Gottlieb’s legacy could be felt for years | Modern Healthcare | 6/15/2019

… from his positions as a fellow at the conservative American Enterprise Institute and a special partner at venture capital firm New Enterprise Associates, and Modern Healthcare took the unprecedented step to put him atop the … medical products and services practices, citing the FDA clearing the Apple Watch for heartbeat monitoring as well as the agency’s Digital Health Software Precertification Program. The FDA also tried to bolster the pharmaceutical and device …

Founders Fund

CIT Recognizes Veteran-Led Virginia Startups During National Veterans Small Business Week | Globe Newswire | 11/4/2019

… c-suite executives spread across 32 of 219 CIT GAP Funds portfolio companies. Bolstered by the formation of the Virginia Founders Fund in 2018, CIT maintains a strong commitment to continue investing in veteran entrepreneurs … angel and strategic investors, and venture capital firms such as New Enterprise Associates, Grotech Ventures, Valhalla Partners, Harbert Venture Partners HIG Ventures, Edison Ventures, In-Q-Tel, Intersouth Partners, SJF Ventures, Carilion Health Systems, Johnson …

Andreessen Horowitz

The Weekly Notable Startup Funding Report: 11/4/19 | 11/3/2019

… Andreessen Horowitz, DST Global, New Enterprise Associates, Ribbit Capital, and Sequoia Capital. Scopely $200.0M - Series D Culver City-based Scopely is an interactive entertainment and mobile games company. Founded by Ankur Bulsara, Eric Futoran, Eytan Elbaz, and Walter Driver in 2011, Scopely has now raised a total of $458.5M in total equity funding and is backed by investors that include BoxGroup, Felicis Ventures, New Enterprise Associates, Revolution, and Science. Faire …

Term Sheet: Oct. 31, 2019 | 10/31/2019

… Ampersand Capital Partners and Thermo Fisher. - Tmunity Therapeutics , a Philadelphia-based biotherapeutics company, raised $75 million in Series B funding. Andreessen Horowitz led the round, and was joined by investors including Westlake Village BioPartners, Gilead … million in 2018 and has yet to post a revenue. New Enterprise Associates (32% pre-offering), Versant Ventures (32%) and Invus Opportunities (11.8%). It plans to list on the Nasdaq as “OYST.” Read more . EXITS …

Sequoia Capital

The Weekly Notable Startup Funding Report: 11/4/19 | 11/3/2019

… New Enterprise Associates, Ribbit Capital, and Sequoia Capital. Scopely $200.0M - Series D Culver City-based Scopely is an interactive entertainment and mobile games company. Founded by Ankur Bulsara, Eric Futoran, Eytan Elbaz, and Walter Driver in 2011, Scopely has now raised a total of $458.5M in total equity funding and is backed by investors that include BoxGroup, Felicis Ventures, New Enterprise Associates, Revolution, and Science. Faire $150.0M - Series D San …

Term Sheet: Oct. 29, 2019 | 10/29/2019

… from a year earlier. An IPO would create a big windfall for early investors such as the Chinese arm of Sequoia Capital, and would also help SoftBank at a time when the value of its … raised $200 million for a 5G ecosystem venture fund. PEOPLE - New Enterprise Associates promoted Ed Mathers to general partner. . IF YOU LIKE THIS EMAIL… Share today’s Term Sheet with a friend . Did someone share this …

Lightspeed Venture Partners

The Weekly Notable Startup Funding Report: 11/4/19 | 11/3/2019

… raised a total of $912.0M in total equity funding and is backed by investors that include Andreessen Horowitz, DST Global, New Enterprise Associates, Ribbit Capital, and Sequoia Capital. Scopely $200.0M - Series D Culver City-based … is backed by investors that include DST Global, Founders Fund, Lightspeed Venture Partners, Sequoia Capital, and Y Combinator. Vacasa $319.0M - Series C Portland-based Vacasa is a vacation rental management company that helps homeowners buy …

Term Sheet: Oct. 28, 2019 | 10/28/2019

… of between $14 to $16. It has yet to post a revenue and posted losses of $30 million in 2018. New Enterprise Associates (20.4% pre-offering), Novartis Bioventures (17%), and Novo Nordisk (15%) back the … fifth European buyout fund, according to Bloomberg. Read more. PEOPLE - Lightspeed Venture Partners hired Mercedes Bent, James Ephrati, Anoushka Vaswani and Rytis Vitkauskas as partners. . IF YOU LIKE THIS EMAIL… Share today’s Term Sheet with …

Qualcomm Ventures

The Weekly Notable Startup Funding Report: 11/4/19 | 11/3/2019

… Qualcomm Ventures, and SOSV. Robinhood $50.0M - Series E Menlo Park-based Robinhood is a stock brokerage that allows customers to buy and sell U.S. stocks, options, ETFs, and cryptocurrencies with zero commission. Founded by Baiju Bhatt and Vlad Tenev in 2013, Robinhood has now raised a total of $912.0M in total equity funding and is backed by investors that include Andreessen Horowitz, DST Global, New Enterprise Associates, Ribbit Capital, and …

Term Sheet: Oct. 31, 2019 | 10/31/2019

… and Peak State Ventures. - Particle , a San Francisco-based internet of things platform, raised $40 million in Series C funding. Qualcomm Ventures LLC and Energy Impact Partners led the round, and were joined by investors … million in 2018 and has yet to post a revenue. New Enterprise Associates (32% pre-offering), Versant Ventures (32%) and Invus Opportunities (11.8%). It plans to list on the Nasdaq as “OYST.” Read more . EXITS …

Index Ventures

Instabase lands $105M in Series B funding towards its custom app platform | 10/31/2019

Instabase, the platform company for business applications, today announced that it has raised $105 million in Series B funding, led by Index Ventures with participation from existing investors Greylock Partners, New Enterprise Associates (NEA), and Andreessen Horowitz. Additional participating investors include Spark Capital, Tribe Capital, SC Ventures, and Glynn Capital. This latest round brings Instabase ’s total funding to $132 million and values the company at over $1 billion. Instabase …

Instabase: $105 Million In Funding At $1.05 Billion Valuation | 10/28/2019

Business application platform company Instabase announced recently that it raised $105 million in Series B funding at a $1.05 billion valuation Instabase — a business application platform company — announced recently that it raised $105 million in Series B funding led by Index Ventures with participation from existing investors Greylock Partners, New Enterprise Associates (NEA), and Andreessen Horowitz. And additional participating investors include Spark Capital, Tribe Capital, SC Ventures, and Glynn Capital …

Goldman Sachs

Term Sheet: Oct. 31, 2019 | 10/31/2019

… science automation platform, raised $23 million in Series A funding, JAFCO led the round, and was joined by investors including Goldman Sachs and NEC Corporation. - Crimson Education , a New Zealand-based edtech and college admissions … million in 2018 and has yet to post a revenue. New Enterprise Associates (32% pre-offering), Versant Ventures (32%) and Invus Opportunities (11.8%). It plans to list on the Nasdaq as “OYST.” Read more . EXITS …

Term Sheet: Oct. 29, 2019 | 10/29/2019

… IPM Group, and Pangaea Ventures. - Twiga Foods , a Kenya-based food distribution startup, raised $30 million in debt and equity. Goldman Sachs led the round. - Duffel , a U.K.-based travel tech company, raised $30 million … raised $200 million for a 5G ecosystem venture fund. PEOPLE - New Enterprise Associates promoted Ed Mathers to general partner. . IF YOU LIKE THIS EMAIL… Share today’s Term Sheet with a friend . Did someone share this …

Greylock Partners

Instabase lands $105M in Series B funding towards its custom app platform | 10/31/2019

Instabase, the platform company for business applications, today announced that it has raised $105 million in Series B funding, led by Index Ventures with participation from existing investors Greylock Partners, New Enterprise Associates (NEA), and Andreessen Horowitz. Additional participating investors include Spark Capital, Tribe Capital, SC Ventures, and Glynn Capital. This latest round brings Instabase ’s total funding to $132 million and values the company at over $1 billion. Instabase …

Instabase: $105 Million In Funding At $1.05 Billion Valuation | 10/28/2019

Business application platform company Instabase announced recently that it raised $105 million in Series B funding at a $1.05 billion valuation Instabase — a business application platform company — announced recently that it raised $105 million in Series B funding led by Index Ventures with participation from existing investors Greylock Partners, New Enterprise Associates (NEA), and Andreessen Horowitz. And additional participating investors include Spark Capital, Tribe Capital, SC Ventures, and Glynn Capital …

Khosla Ventures

Term Sheet: Oct. 31, 2019 | 10/31/2019

… platform, raised $50 million in Series C funding. Evolution Ventures led the round, and was joined by investors including Macy’s, Khosla Ventures, and Peak State Ventures. - Particle , a San Francisco-based internet of things platform … million in 2018 and has yet to post a revenue. New Enterprise Associates (32% pre-offering), Versant Ventures (32%) and Invus Opportunities (11.8%). It plans to list on the Nasdaq as “OYST.” Read more . EXITS …

Indian startup fundraising data- 2nd week Oct-19 – 2Startups | Indian Startups Success Stories | 10/14/2019

… HR automation startup Greytip raised a total of $10.1 million in 3 rounds of funding from 4 investors. Blume Ventures, New Enterprise Associates, and MegaDelta Capital are other investors in the HR startup GReytip. Hevo … marketplace Vahan.ai raised an undisclosed amount of fresh funding from Khosla Ventures, and San Francisco-based venture funds Founders Fund and Pioneer Fund- Y Combinator Alumni supporting fund. GeoIQ : A Bengaluru-based location intelligence startup …

GSV Capital

Coursera and MathWorks Announce New Data Science Course | 10/31/2019

… New Enterprise Associates, GSV Capital, Learn Capital, and SEEK Group. About MathWorks MathWorks is the leading developer of mathematical computing software. MATLAB, the language of engineers and scientists, is a programming environment for algorithm development, data analysis, visualization, and numeric computation. Simulink is a block diagram environment for simulation and Model-Based Design of multidomain and embedded engineering systems. Engineers and scientists worldwide rely on these product families to accelerate …

Harvard Medical School

New Aetion Tool Brings Real-World Evidence Research to Small and Mid-Sized Pharma Companies | PR Newswire | 11/1/2019

Harvard Medical School faculty with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era. Aetion is based in New York City , and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, Amgen Ventures …

New Aetion Tool Brings Real-World Evidence Research to Small and Mid-Sized Pharma Companies | The Wapakoneta Daily News | 11/1/2019

Harvard Medical School faculty with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era. Aetion is based in New York City , and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, Amgen Ventures …

MemorialCare

No. 450: Worlds war, bombs blast and Delta delivers – plus, an all-time LI great calls it a career (kinda) | 10/30/2019

… in funding led by First Trust Capital Partners, with participation from Sumitomo Corporation of Americas, Ziegler, Cedars-Sinai Health System, MemorialCare, St. Luke’s University Health Network and The University of Kansas Health System, among others … Capital Partners, Correlation Ventures, A&E Investment, Osage University Partners, New Enterprise Associates, GV and Amazon. Fashion police: Good luck at your trial, Liz. BELOW THE FOLD (All Hallows Eve Edition) That’s some great pumpkin …

Term Sheet: Oct. 29, 2019 | 10/29/2019

… round. - Twistle , an Albuquerque, N.M.-based healthcare communications platform, raised $16 million in Series A funding. Health Enterprise Partners and MemorialCare Innovation Fund co-led the round. - ESS Inc. , a Wilsonville, Ore.-based manufacturer of … raised $200 million for a 5G ecosystem venture fund. PEOPLE - New Enterprise Associates promoted Ed Mathers to general partner. . IF YOU LIKE THIS EMAIL… Share today’s Term Sheet with a friend . Did someone share this …

HCA

Circular Logic - A Revolving Door Update | 10/27/2019

… Cynthia Ridgeway, From Department of Justice Prosecuting White Collar Crimes to Anthem As reported on July 15, 2019 by Modern Healthcare: Health insurer Anthem has hired Cynthia Ridgeway, a longtime attorney for the U.S. Justice … in 2019, Dr Gottlieb rejoined his old venture capital firm, New Enterprise Associates, as a full-time partner investing partner specializing in life sciences companies. Then in June, 2019, he joined the board of Pfizer …

Investors’ deep-pocket push to defend surprise medical bills | MedCity News | 9/11/2019

New Enterprise Associates ) and a trio of staffing firms called US Acute Care Solutions, US Radiology Specialists and US Anesthesia partners (all partly owned by the investment firm Welsh, Carson, Anderson and Stowe ). Among the groups listed as lobbying on surprise bills are hospital groups like Christus Health (which uses EmCare ) and Wellstar Health Systems (which uses ApolloMD ). In addition, HCA , a large hospital chain that has had a joint …

Ascension

Ivantis Completes Enrollment of International SPECTRUM Registry for Hydrus Microstent | PR Newswire | 10/10/2019

… New Enterprise Associates, Delphi Ventures, Foresite Capital, RA Capital Management, Ascension Ventures, EDBI, GBS Ventures, MemorialCare Innovation Fund, Merieux Development and Vertex HealthCare. The company is headquartered in Irvine, California . Ivantis® and Hydrus® are registered trademarks of Ivantis Inc. All rights reserved. 2019. www.IvantisInc.com Media Contact Capwell Communications Lynne Russo [email protected] 818-903-6079 SOURCE Ivantis, Inc. Related Links http://www.ivantisinc.com …

Ivantis Announces Groundbreaking 3 Year Results from FDA Clinical Trial; First Device in Minimally Invasive Glaucoma Surgical (MIGS) Category to Demonstrate Significant Long Term Reduction of Severe Major Surgeries for Glaucoma Patients | PR Newswire | 5/2/2019

New Enterprise Associates, Delphi Ventures, Foresite Capital, RA Capital Management, Ascension Ventures, EDBI, GBS Ventures, MemorialCare Innovation Fund, Merieux Development, and Vertex Healthcare. The company is headquartered in Irvine, Calif. www.IvantisInc.com Ivantis ® and Hydrus ® are registered trademarks of Ivantis, Inc. All rights reserved 2019. Media Contact Ivantis Inc. Linda Scotton [email protected] (949) 333-1323 SOURCE Ivantis, Inc. Related Links http://www.IvantisInc.com …

Johns Hopkins Medicine

Parvus Therapeutics Announces Key Executive and Board of Directors Appointments | Business Wire | 7/16/2019

… FerroKin BioSciences, which was acquired by Shire Plc in 2012. Earlier in his career, Dr. Rienhoff was involved in venture capital as a Director at Abingworth Management in London and a partner at New Enterprise Associates (NEA). Throughout his career, Dr. Rienhoff has held numerous board positions in life science companies, many of which lead to successful exits. He obtained his B.A. from Williams College, studied mathematics at Harvard University …

Parvus Therapeutics Announces Key Executive and Board of Directors Appointments | Business & Finance | manchestertimes.com | Business Wire | 7/16/2019

… FerroKin BioSciences, which was acquired by Shire Plc in 2012. Earlier in his career, Dr. Rienhoff was involved in venture capital as a Director at Abingworth Management in London and a partner at New Enterprise Associates (NEA). Throughout his career, Dr. Rienhoff has held numerous board positions in life science companies, many of which lead to successful exits. He obtained his B.A. from Williams College, studied mathematics at Harvard University …

Johns Hopkins University School of Medicine

Parvus Therapeutics Announces Key Executive and Board of Directors Appointments | Business Wire | 7/16/2019

New Enterprise Associates (NEA). Throughout his career, Dr. Rienhoff has held numerous board positions in life science companies, many of which lead to successful exits. He obtained his B.A. from Williams College, studied mathematics at Harvard University and earned an M.D. from the Johns Hopkins University School of Medicine. He trained in internal medicine as a member of the Osler Medical House staff at the Johns Hopkins Hospital where he …

Parvus Therapeutics Announces Key Executive and Board of Directors Appointments | Business & Finance | manchestertimes.com | Business Wire | 7/16/2019

New Enterprise Associates (NEA). Throughout his career, Dr. Rienhoff has held numerous board positions in life science companies, many of which lead to successful exits. He obtained his B.A. from Williams College, studied mathematics at Harvard University and earned an M.D. from the Johns Hopkins University School of Medicine. He trained in internal medicine as a member of the Osler Medical House staff at the Johns Hopkins Hospital where he …

Massachusetts General Hospital

Akouos to Build Premier Gene Therapy Company Focused on Hearing and Balance Disorders with Backing from Leading Life Science Investors and Strategic Licenses from Massachusetts Eye and Ear and Lonza | PR Newswire | 11/30/2017

… and Strategic Licenses from Massachusetts Eye and Ear and Lonza - Akouos raises $7.5 million in equity financing from 5AM Ventures, New Enterprise Associates (NEA), and Partners Innovation Fund.- Massachusetts Eye and Ear and Lonza grant … Ph.D., Chief of Otolaryngology at Massachusetts Eye and Ear and Massachusetts General Hospital and the Walter Augustus LeCompte Professor and Chair of Otolaryngology at Harvard Medical School and Joan W. Miller , M.D., Chief of Ophthalmology …

Dignity Health

NEA Promotes Aaron Jacobson To Partner, Welcomes Kavita Patel As Venture Partner | PR Newswire | 11/16/2017

… Jacobson To Partner, Welcomes Kavita Patel As Venture Partner News provided by 10:00 MENLO PARK, Calif. Global venture capital firm New Enterprise Associates, Inc. (NEA) today announced the promotion of Aaron Jacobson to Partner. Jacobson … welcome her to the team.” Patel is a director of Dignity Health , Tesaro , and SSM Health Care . She frequently provides expert commentary to radio and print media outlets, including National Public Radio, CBS, Newsweek and …

SSM Health

NEA Promotes Aaron Jacobson To Partner, Welcomes Kavita Patel As Venture Partner | PR Newswire | 11/16/2017

… Jacobson To Partner, Welcomes Kavita Patel As Venture Partner News provided by 10:00 MENLO PARK, Calif. Global venture capital firm New Enterprise Associates, Inc. (NEA) today announced the promotion of Aaron Jacobson to Partner. Jacobson … team.” Patel is a director of Dignity Health , Tesaro , and SSM Health Care . She frequently provides expert commentary to radio and print media outlets, including National Public Radio, CBS, Newsweek and MarketWatch. Patel earned her …

Donald Trump

Trump to Nominate Stephen Hahn, MD, for FDA Commissioner | 11/1/2019

Stephen Hahn, MD, chief medical executive of The University of Texas MD Anderson Cancer Center, has been named by President Donald Trump as his nominee to run the FDA. [The University of Texas MD Anderson Cancer Center] Share Stephen Hahn, MD, chief medical executive of The University of Texas MD Anderson Cancer Center, was named today by President Donald Trump as his nominee to run the FDA. If confirmed by …

Former FDA Commissioner Gottlieb defends decision to join Pfizer board | CNBC | 7/2/2019

… New Enterprise Associates, where he worked before joining the FDA. He also joined CNBC as a contributor. It’s not uncommon for government officials to join the sector they regulated after leaving the administration. However, President Donald Trump, who appointed Gottlieb, has made “draining the swamp” one of his main priorities. “I worked with some large drugmakers before I came into the agency,” Gottlieb said, adding that his new role at …

Scott Gottlieb

Rock-Bottom Drug Prices For Older Generic Drugs Contribute To Worsening Shortages, FDA Says | Kaiser Health News | 10/30/2019

Scott Gottlieb is focused on an area where few have found success in recent years: developing new antibiotics. Since leaving the FDA in April, Gottlieb has revealed little about what types of investments he would make in his new role at New Enterprise Associates, one of the country’s largest venture capital firms where he worked prior to his time in government. (Spalding, 10/29) The Hill: House Democrats Clash Over Pelosi’s …

Ex-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics | Yahoo News | 10/29/2019

As a private investor, former U.S. Food and Drug Administration Commissioner Scott Gottlieb is focused on an area where few have found success in recent years: developing new antibiotics.” data-reactid=”23” NEW YORK (Reuters … of investments he would make in his new role at New Enterprise Associates, one of the country’s largest venture capital firms where he worked prior to his time in government. But in an interview, Gottlieb …

Mohamad Makhzoumi

NEA promotes two | PE Hub | 10/28/2019

New Enterprise Associates Inc has promoted Ed Mathers to general partner. Also, the firm has promoted Blake Wu to partner on the healthcare investing team. Mathers first joined NEA in 2008 while Wu came on … mentor and train talented individuals from within our partnership,” said Mohamad Makhzoumi, General Partner and head of healthcare services and healthcare IT investing at NEA. “Blake is a prime example of someone who joined NEA …

NEA Promotes Ed Mathers to General Partner and Blake Wu to Partner | PR Newswire | 10/28/2019

MENLO PARK, Calif. , Oct. 28, 2019 /PRNewswire/ – New Enterprise Associates , Inc. (NEA) today announced the promotion of Ed Mathers , a healthcare investor focused on biotechnology and specialty pharmaceuticals, to General Partner. Since joining NEA in … mentor and train talented individuals from within our partnership,” said Mohamad Makhzoumi , General Partner and head of healthcare services and healthcare IT investing at NEA. “Blake is a prime example of someone who joined NEA …

Jeff Immelt

What’s next in healthcare and digital health? Here are 4 trends to watch | FierceHealthcare | 10/5/2019

… Jeff Immelt, former chairman and CEO of GE and now venture partner at New Enterprise Associates. The next generation of AI healthcare companies will have a hard time getting funding, especially those that are oblique about where the benefits come from, he said during the CB Insights conference. Digital health and AI healthcare startups should focus on delivering better outcomes and solving problems that are right in front of them …

Startup Arris, Incubated In Ex-Autodesk CEO’s Personal Shop, Comes Out Of Stealth With New Way Of Manufacturing Composites And $10M Funding | Forbes | 5/20/2019

New Enterprise Associates, which sent Jeff Immelt, GE’s former CEO and now a venture partner there, to vet the technology. “What we did in automotive to replace non-structural metal with low cost/lightweight injection molded composites in the 1980s, Arris has now enabled for the rest of the vehicle,” Immelt said in a statement. Strength, weight, speed and cost are huge issues in manufacturing, and have always required tradeoffs …

Jonathan Bush

Scott Gottlieb joins Aetion’s board, Jonathan Bush named executive chairman of Firefly, and more digital health hires and departures | MobiHealthNews | 9/19/2019

… of Fitbit Health; Cala Health appoints Renee Ryan as CEO; Craig Maloney joins Maestro Health. Scott Gottlieb joins Aetion’s board, Jonathan Bush named executive chairman of Firefly, and more digital health hires and departures Former … include roles with nonprofit drug development group FasterCures, Pfizer and New Enterprise Associates. Former general manager of Fitbit Health Solutions Adam Pellegrini has departed the wearables maker in favor of a new role as SVP …

Scott Gottlieb joins Ateon’s board, Jonathan Bush named executive chairman of Firefly, and more digital health hires and departures | MobiHealthNews | 9/19/2019

… of Fitbit Health; Cala Health appoints Renee Ryan as CEO; Craig Maloney joins Maestro Health. Scott Gottlieb joins Ateon’s board, Jonathan Bush named executive chairman of Firefly, and more digital health hires and departures September … include roles with nonprofit drug development group FasterCures, Pfizer and New Enterprise Associates. Former general manager of Fitbit Health Solutions Adam Pellegrini has departed the wearables maker in favor of a new role as SVP …

Adam Pellegrini

Scott Gottlieb joins Aetion’s board, Jonathan Bush named executive chairman of Firefly, and more digital health hires and departures | MobiHealthNews | 9/19/2019

… New Enterprise Associates. Former general manager of Fitbit Health Solutions Adam Pellegrini has departed the wearables maker in favor of a new role as SVP of transformation consumer health products at CVS , CNBC first reported earlier this month. Citing a memo from the company’s chief transformation officer, Alan Lotvin, Pellegrini will “lead the ideation and incubation of consumer-focused health products and services that drive enterprise value and growth.” Prior …

Scott Gottlieb joins Ateon’s board, Jonathan Bush named executive chairman of Firefly, and more digital health hires and departures | MobiHealthNews | 9/19/2019

… New Enterprise Associates. Former general manager of Fitbit Health Solutions Adam Pellegrini has departed the wearables maker in favor of a new role as SVP of transformation consumer health products at CVS , CNBC first reported earlier this month. Citing a memo from the company’s chief transformation officer, Alan Lotvin, Pellegrini will “lead the ideation and incubation of consumer-focused health products and services that drive enterprise value and growth.” Prior …

Alan Lotvin

Scott Gottlieb joins Aetion’s board, Jonathan Bush named executive chairman of Firefly, and more digital health hires and departures | MobiHealthNews | 9/19/2019

… New Enterprise Associates. Former general manager of Fitbit Health Solutions Adam Pellegrini has departed the wearables maker in favor of a new role as SVP of transformation consumer health products at CVS , CNBC first reported earlier this month. Citing a memo from the company’s chief transformation officer, Alan Lotvin, Pellegrini will “lead the ideation and incubation of consumer-focused health products and services that drive enterprise value and growth.” Prior …

Scott Gottlieb joins Ateon’s board, Jonathan Bush named executive chairman of Firefly, and more digital health hires and departures | MobiHealthNews | 9/19/2019

… New Enterprise Associates. Former general manager of Fitbit Health Solutions Adam Pellegrini has departed the wearables maker in favor of a new role as SVP of transformation consumer health products at CVS , CNBC first reported earlier this month. Citing a memo from the company’s chief transformation officer, Alan Lotvin, Pellegrini will “lead the ideation and incubation of consumer-focused health products and services that drive enterprise value and growth.” Prior …

Michael Zeisser

High School Esports Company PlayVS Raises $50 Million In Series C | Forbes | 9/18/2019

PlayVS, which develops software used to operate high school esports competitions, announced today that it had completed a $50 million Series C funding round. The round was led by New Enterprise Associates , which also headed up the company’s $15 million Series A in summer 2018. Other investors in the round include Battery Ventures; CAA cofounder Michael Ovitz; early-stage venture fund Sapphire Sport; Michael Zeisser , former head of U.S. investments …

Daphne Koller

Global Medicines Company Collaborates With Coursera to Power Innovation Through Learning | Business Wire | 9/12/2019

… and an easy-to-use mobile platform. For more information, visit https://www.coursera.org/business/ . About Coursera: Coursera was founded by Daphne Koller and Andrew Ng with a vision of providing life-transforming learning experiences to … workforce. Coursera is backed by investors that include Kleiner Perkins, New Enterprise Associates, GSV Capital, Learn Capital, and SEEK Group. Contacts Andy Lutzky [email protected]

Global Medicines Company Collaborates With Coursera to Power Innovation Through Learning | Business & Finance | manchestertimes.com | Business Wire | 9/12/2019

… and an easy-to-use mobile platform. For more information, visit https://www.coursera.org/business/ . About Coursera: Coursera was founded by Daphne Koller and Andrew Ng with a vision of providing life-transforming learning experiences to … workforce. Coursera is backed by investors that include Kleiner Perkins, New Enterprise Associates, GSV Capital, Learn Capital, and SEEK Group. View source version on businesswire.com : https://www.businesswire.com/news/home/20190912005255/en/ CONTACT: Andy Lutzky KEYWORD …

Elon Musk

What Happens When Hype Meets Reality: Term Sheet | Fortune | 9/9/2019

… the business and reportedly joked that dealing with the Securities and Exchange Commission during the IPO process helped him understand Elon Musk better, according to The WSJ. In my opinion, WeWork’s current predicament isn’t very … led the round, and was joined by investors including Benchmark, New Enterprise Associates, Dragoneer Investment Group and EQT Ventures. – BrightInsight, Inc , a San Jose, Calif.-based online platform for biopharama and medtech, raised $25 million …

Venture Capital Investing Hits Highest Since Dot-Com Boom - Bloomberg | 1/9/2018

Elon Musk’s Space Exploration Technologies Corp. Venture firms started 209 funds that raised a total of $32 billion, including New Enterprise Associates’ $3.3 billion vehicle raised in June 2017, the largest ever raised. Other notable funds raised in the final few months of the year included a $450 million life sciences fund at Andreessen Horowitz and a $400 million fund at Redpoint Ventures. SoftBank isn’t included in this total because …